These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9056949)

  • 1. Monoclonal antibodies from three new regions of huntingtin, the Huntington's disease protein.
    Wilkinson F; Nguyen TM; Morris GE
    Biochem Soc Trans; 1997 Feb; 25(1):51S. PubMed ID: 9056949
    [No Abstract]   [Full Text] [Related]  

  • 2. New clues found to Huntington's.
    Barinaga M
    Science; 1995 Nov; 270(5239):1110. PubMed ID: 7502028
    [No Abstract]   [Full Text] [Related]  

  • 3. Localization of rabbit huntingtin using a new panel of monoclonal antibodies.
    Wilkinson FL; Nguyen TM; Manilal SB; Thomas P; Neal JW; Harper PS; Jones AL; Morris GE
    Brain Res Mol Brain Res; 1999 May; 69(1):10-20. PubMed ID: 10350633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
    Trottier Y; Devys D; Imbert G; Saudou F; An I; Lutz Y; Weber C; Agid Y; Hirsch EC; Mandel JL
    Nat Genet; 1995 May; 10(1):104-10. PubMed ID: 7647777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis.
    Passani LA; Bedford MT; Faber PW; McGinnis KM; Sharp AH; Gusella JF; Vonsattel JP; MacDonald ME
    Hum Mol Genet; 2000 Sep; 9(14):2175-82. PubMed ID: 10958656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.
    Khoshnan A; Ko J; Patterson PH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1002-7. PubMed ID: 11792860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity.
    Dehay B; Weber C; Trottier Y; Bertolotti A
    Biotechnol J; 2007 May; 2(5):559-64. PubMed ID: 17373643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.
    Colby DW; Garg P; Holden T; Chao G; Webster JM; Messer A; Ingram VM; Wittrup KD
    J Mol Biol; 2004 Sep; 342(3):901-12. PubMed ID: 15342245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
    Hoffner G; Island ML; Djian P
    J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against huntingtin: production and screening of monoclonals and single-chain recombinant forms.
    Khoshnan A; Ou S; Ko J; Patterson PH
    Methods Mol Biol; 2004; 277():87-102. PubMed ID: 15201451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.
    Hackam AS; Singaraja R; Zhang T; Gan L; Hayden MR
    Hum Mol Genet; 1999 Jan; 8(1):25-33. PubMed ID: 9887328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.
    Gutekunst CA; Levey AI; Heilman CJ; Whaley WL; Yi H; Nash NR; Rees HD; Madden JJ; Hersch SM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8710-4. PubMed ID: 7568002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intriguing new lead on Huntington's disease.
    Barinaga M
    Science; 1996 Mar; 271(5253):1233-4. PubMed ID: 8638101
    [No Abstract]   [Full Text] [Related]  

  • 15. Huntingtin Fibrils Poke Membranes.
    Guedes-Dias P; Holzbaur ELF
    Cell; 2017 Sep; 171(1):32-33. PubMed ID: 28938121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
    Lunkes A; Mandel JL
    Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Huntington's a glutamine storage disease?
    Brusilow WS
    Neuroscientist; 2006 Aug; 12(4):300-4. PubMed ID: 16840706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
    Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
    Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.
    Trottier Y; Lutz Y; Stevanin G; Imbert G; Devys D; Cancel G; Saudou F; Weber C; David G; Tora L
    Nature; 1995 Nov; 378(6555):403-6. PubMed ID: 7477379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.
    Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM
    Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.